Adjuvant chemotherapy with CEF versus CMF for node-positive breast cancer.
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 1998
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Adult (MeSH)
- Antineoplastic Combined Chemotherapy Protocols (MeSH)
- Breast Neoplasms (MeSH)
- Cyclophosphamide (MeSH)
- Cytarabine (MeSH)
- Epirubicin (MeSH)
- Female (MeSH)
- Fluorouracil (MeSH)
- Humans (MeSH)
- Lymphatic Metastasis (MeSH)
- Methotrexate (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Proportional Hazards Models (MeSH)
- Randomized Controlled Trials as Topic (MeSH)
- Research Design (MeSH)
published in
- Journal of Clinical Oncology Journal